Folic acid prevents congenital malformations in the offspring of diabetic mice

Endocrine Journal

Volumn 56, Issue 1, 2009, Pages 29-37

  Oyama, Kaori ^a   Sugimura, Yoshihisa ^a,b   Murase, Takashi ^a   Uchida, Akira ^a   Hayasaka, Shizu ^a   Oiso, Yutaka ^b   Murata, Yoshiharu ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Diabetes mellitus; Embryopathy; Folic acid; Homocysteine

Indexed keywords

FOLIC ACID; GLUCOSE; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MALFORMATION; CARDIOVASCULAR MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GLUCOSE BLOOD LEVEL; MOUSE; NEURAL TUBE DEFECT; NICK END LABELING; NONHUMAN; VITAMIN SUPPLEMENTATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; EMBRYO, MAMMALIAN; FEMALE; FETAL WEIGHT; FOLIC ACID; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED ICR; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; STREPTOZOCIN;

EID: 62549091501     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-180     Document Type: Article

References (49)

1. Eriksson UJ, Cederberg J, Wentzel P (2003) Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev Endocr Metab Disord 4: 79-93.
2. Machado AF, Zimmerman EF, Hovland DN, Jr., Weiss R, Collins MD (2001) Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele. Diabetes 50: 1193-1199.
3. Mills JL (1982) Malformations in infants of diabetic mothers. Teratology 25: 385-394.
4. Mills JL, Baker L, Goldman AS (1979) Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28: 292-293.
5. Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Bmj 328: 915.
6. Kuhl C, Coustan D, Kitzmiller J, Philipps A, Binder C, Schneider H (1998) Report on the 28th annual meeting of the Diabetic Pregnancy Study Group. Diabetologia 41: suppl 8-14.
7. Suhonen L, Hiilesmaa V, Teramo K (2000) Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43: 79-82.
8. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
9. Centers for Disease Control (CDC) (1991) Use of folic acid for prevention of spina bifida and other neural tube defects-1983-1991. MMWR Morb Mortal Wkly Rep 40: 513-516.
10. Czeizel AE, Toth M, Rockenbauer M (1996) Population-based case control study of folic acid supplementation during pregnancy. Teratology 53: 345-351.
11. Mills JL, Signore C (2004) Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol 70: 844-845.
12. Botto LD, Khoury MJ, Mulinare J, Erickson JD (1996) Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population- based, case-control study. Pediatrics 98: 911-917.
13. Botto LD, Mulinare J, Erickson JD (2000) Occurrence of congenital heart defects in relation to maternal muli- tivitamin use. Am J Epidemiol 151: 878-884.
14. Czeizel AE (1996) Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62: 179-183.
15. Hayes C, Werler MM, Willett WC, Mitchell AA (1996) Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 143: 1229-1234.
16. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM (1995) Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346: 393-396.
17. Tolarova M, Harris J (1995) Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51: 71-78.
18. Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA (1999) Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150: 675-682.
19. Yang Q, Khoury MJ, Olney RS, Mulinare J (1997) Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring? Epidemiology 8: 157- 161.
20. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS (1995) Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6: 212-218.
21. Sato N, Sugimura Y, Hayashi Y, Murase T, Kanou Y, Kikkawa F, Murata Y (2008) Identification of genes differentially expressed in mouse fetuses from strepto- zotocin-induced diabetic pregnancy by cDNA subtraction. Endocr J 55: 317-323.
22. Wentzel P, Gareskog M, Eriksson UJ (2005) Folic acid supplementation diminishes diabetes- and glucose- induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 54: 546-553.
23. Eriksson U, Dahlstrom E, Larsson KS, Hellerstrom C (1982) Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31: 1-6.
24. Siman CM, Eriksson UJ (1997) Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46: 1054-1061.
25. Hoshino K, Oda S, Fukui Y, Kameyama Y (1988) Strain differences in teratogenic susceptibility to trypan blue between WM and BDIX rat strains. Teratology 37: 43-50.
26. Nishimura K (1974) A microdissection methods for detecting thoracic visceral malformations in mouse and rat fetuses. Congenital Anomarlies 14: 23-40.
27. Wilson JG (1965) Methods of administering agents and detecting malformations in experimental animals: The University of Chicago Press.
28. Inouye M (1976) Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and aizarin red S. Congenital Anomarlies 16: 171-173.
29. Malek FA, Moritz KU, Fanghanel J, Bienengraber V (2004) Reduction of procarbazine-induced cleft palates by prenatal folic acid supplementation in rats. Pathol Res Pract 200: 33-40.
30. Quinn PB, Cremin FM, O'Sullivan VR, Hewedi FM, Bond RJ (1990) The influence of dietary folate supplementation on the incidence of teratogenesis in zinc- deficient rats. Br J Nutr 64: 233-243.
31. Zhu MX, Zhou SS (1989) Reduction of the teratogenic effects of phenytoin by folic acid and a mixture of folic acid, vitamins, and amino acids: a preliminary trial. Epilepsia 30: 246-251.
32. Harris MJ, Juriloff DM (1999) Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology 60: 292-305.
33. Juriloff DM, Harris MJ (2000) Mouse models for neural tube closure defects. Hum Mol Genet 9: 993- 1000.
34. Naruse I, Keino H (1995) Apoptosis in the developing CNS. Prog Neurobiol 47: 135-155.
35. Weil M, Jacobson MD, Raff MC (1997) Is programmed cell death required for neural tube closure? Curr Bioll: 281-284.
36. Kirby ML, Gale TF, Stewart DE (1983) Neural crest cells contribute to normal aorticopulmonary septation. Science 220: 1059-1061.
37. Suzuki N, Svensson K, Eriksson UJ (1996) High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 39: 401-411.
38. Chang TI, Horal M, Jain SK, Wang F, Patel R, Loeken MR (2003) Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46: 538-545.
39. Tang LS, Wlodarczyk BJ, Santillano DR, Miranda RC, Finnell RH (2004) Developmental consequences of abnormal folate transport during murine heart morphogenesis. Birth Defects Res A Clin Mol Teratol 70: 449-458.
40. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ (2001) Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 226: 243-270.
41. Mills JL, Scott JM, Kirke PN, McPartlin JM, Conley MR, Weir DG, Molloy AM, Lee YJ (1996) Homocysteine and neural tube defects. J Nutr 126: 756S-760S.
42. Rosenquist TH, Ratashak SA, Selhub J (1996) Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93: 15227-15232.
43. Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 6: 27-36.
44. Hashimoto M, Akazawa S, Akazawa M, Akashi M, Yamamoto H, Maeda Y, Yamaguchi Y, Yamasaki H, Tahara D, Nakanishi T, et al. (1990) Effects of hyper- glycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 33: 597-602.
45. Sadler TW, Phillips LS, Balkan W, Goldstein S (1986) Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 35: 861-865.
46. Wentzel P, Welsh N, Eriksson UJ (1999) Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 48: 813-820.
47. Robillon JF, Canivet B, Candito M, Sadoul JL, Jullien D, Morand P, Chambon P, Freychet P (1994) Type 1 diabetes mellitus and homocysteine. Diabete Metab 20: 494-496.
48. Schalinske KL (2003) Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine beta-synthase. Nutr Rev 61: 136-138.
49. Kaplan JS, Iqbal S, England BG, Zawacki CM, Herman WH (1999) Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care 22: 1017-1021.